Food & Synthetic Biology CDMO Solutions

Food & Synthetic Biology CDMO Solutions — MycoVista

Fermentation-first pathways for the next wave of food, materials, and climate biotech.

Introduction: Why Food & Synthetic Biology Needs a Purpose-Built CDMO

The future of food, agriculture, and sustainable materials is being shaped by a generation of innovators building with microbes, enzymes, and cell-free systems rather than petrochemicals or animal-derived inputs. From precision-fermented proteins like caseins, whey, and collagen to biopolymers, functional flavors, and biomaterials, the stakes are enormous: scalable, sustainable production is the difference between scientific promise and commercial success.

At MycoVista Food & Synthetic Biology CDMO Solutions, we provide the technical expertise, analytical rigor, and manufacturability-by-default philosophy needed to move synbio programs from lab bench to pilot to commercial stainless steel. Our dual hubs in San Diego and Montréal operate under a unified digital QMS (ALCOA+), ensuring that fermentation runs, analytical data, and techno-economic models are mirrored and inspection-ready across continents.

Food and synbio clients choose MycoVista because we are not a traditional food contractor, and not merely a therapeutic CDMO — we are a hybrid partner that applies GMP-grade bioprocess thinking to food and industrial biology. The result: scalable, reproducible processes supported by documentation you can show to regulators, investors, and downstream partners.

Applications We Support

Precision-Fermented Proteins

  • Recombinant caseins, whey proteins, and collagen to enable animal-free dairy and meat analogues.
  • Strain optimization for high titers and low byproduct accumulation.
  • Downstream purification workflows aligned with food-grade and GMP-style standards.
  • Stability and functionality testing for formulation compatibility.

Functional Enzymes & Flavors

  • Fermentation of enzymes for food processing (proteases, lipases, lactases).
  • Biosynthesis of flavor molecules and functional ingredients.
  • Custom analytics to validate activity, organoleptic performance, and shelf stability.

Biopolymers & Biomaterials

  • Microbial or fungal systems to produce biopolymer precursors (PHA, PLA monomers).
  • Biomaterial scaffolds, fibers, or coatings from engineered microbes.
  • Techno-economic modeling to project cost-per-kg and sustainability impact.

What MycoVista Food & Synthetic Biology CDMO Solutions Adds

  • Strain Engineering → Process Development: We provide upstream strain improvement, fermentation design, and DSP optimization.
  • Techno-Economic Modeling: OPEX/CAPEX modeling, media optimization, yield sensitivity analysis, cost projections for investors.
  • Pilot → Commercial Scale: Fermentation runs from bench-top to pilot (100–1000 L) to 50,000 L stainless steel for qualified programs.
  • Sustainability Dashboards: Carbon footprint, resource use, and cost tracking presented in investor-ready formats.
  • Analytics-First Approach: Characterization of proteins, enzymes, and biopolymers using advanced analytical methods typically reserved for therapeutics.

Key Challenges in Food & SynBio (and How We Solve Them)

1. Scale-Up Risk

Lab-scale fermentation rarely translates directly to 10,000+ liters. Foaming, oxygen transfer, and nutrient limitations can cripple yields.

  • Our solution: Structured QTPP → CQA → CPP mapping and DoE-driven process development at multiple scales, with PAT monitoring.

2. Regulatory Ambiguity

Food and synbio products often fall between food-grade, GRAS, and biopharma regulatory categories.

  • Our solution: Dual-path documentation — food-grade CoAs for commercial customers and GMP-style batch records for regulatory engagement.

3. Investor Pressure

Synbio companies often raise capital on the promise of cost parity with animal- or petrochemical-derived incumbents.

  • Our solution: Techno-economic dashboards that align fermentation yields, OPEX, and COGs to investor expectations.

Program Flow

  1. Technical Deep-Dive – Define application (protein, enzyme, polymer), desired functionality, and regulatory context.
  2. Proposal – Clear scope, cost model, and timeline.
  3. QA Transparency – Access to quality framework; optional audits.
  4. Onboarding (30 Days):
    • QTPP/CQA map.
    • DoE plan for fermentation optimization.
    • Draft control strategy.
    • Gantt + FMEA to align cost, yield, and risk.
  5. Design → Data – DoE execution, PAT-driven decisions, weekly reporting.
  6. Decision Gate – Scale only when manufacturability, cost, and reproducibility are validated.

Analytics That Matter

  • SEC-MALS & LC-MS for protein homogeneity.
  • Activity assays for enzymes (specific activity, stability).
  • Mechanical/physical testing for biopolymers and biomaterials.
  • Sustainability metrics: carbon use, water footprint, yield per input.
  • Lot-to-lot reproducibility: monitored with statistical drift analysis.

Facilities & Scale

  • Microbial & Fungal: Bench → pilot → 50,000 L stainless (qualified).
  • Downstream suites: Filtration, chromatography, drying/formulation.
  • Cleanrooms: ISO 8/7, validated utilities, positive pressure.
  • Support labs: TEA modeling, QC analytics, formulation testing.

Case Examples

  • Caseins for alternative dairy: E. coli expression optimized, DSP intensified, cost modeling demonstrated <$8/kg trajectory.
  • Flavor enzyme: Bacillus fermentation scaled to 20,000 L, reproducible activity across 12 lots, TEA dashboard prepared for Series B raise.
  • Biopolymer precursor: Pichia fermentation with PAT-driven optimization, validated physical properties in pilot fiber spinning.

Why Teams Choose MycoVista Food & Synthetic Biology CDMO Solutions

  • Fermentation-first: Deep expertise in microbial/fungal platforms.
  • Analytics-first: Phase-appropriate, GMP-inspired QC even for food-grade.
  • Techno-economic integration: Cost and sustainability metrics delivered alongside yields.
  • Dual-hub resilience: San Diego + Montréal capacity and mirrored QA systems.
  • Manufacturability by default: Only processes that scale, release reproducibly, and withstand inspection move forward.

Conclusion & Call to Action

Food and synbio innovation requires more than scientific creativity — it demands fermentation expertise, analytical rigor, and investor-ready documentation. At MycoVista Food & Synthetic Biology CDMO Solutions, we deliver all three. From recombinant proteins to biopolymers, we provide the platform, analytics, and cost models that bridge the gap between proof-of-concept and global scale.

Contact info@mycovistabiotech.com today to accelerate your food or synbio pipeline. With MycoVista, every program advances by the principle: Design → GMP, without detours.